SOURCE: SINCLAIR PHARMA PLC.

November 09, 2006 06:00 ET

Sinclair Pharma plc presenting at Rodman & Renshaw 8th Annual Global Healthcare Conference

SURREY, GERMANY -- (MARKET WIRE) -- November 9, 2006 --
8 November 2006, London, UK - Sinclair Pharma plc (AIM: SPH.L), the international specialty pharmaceutical company today announces that its Chief Executive Officer, Dr Michael Flynn, and Chief Financial Officer Jerry Randall, will be presenting at the Rodman & Renshaw 8th Annual Global Healthcare Conference in New York on Wednesday 8 November at 4.30pm.

The presentation can be found at Sinclair's website, at the following page: http://www.sinclairpharma.com/news_reports.php

Sinclair Pharma plc

Sinclair Pharma plc is an international specialty pharmaceutical company. It has a growing sales and marketing operation that is already present in France, Italy, the UK, Spain and Portugal, and a complementary marketing partner network that spans 60 countries.

Sinclair has proven expertise in acquiring or developing commercially attractive and undervalued products, registering these products and bringing them to market within a short time frame. The company focuses on niche therapeutic areas and its current portfolio includes products for dermatological conditions and oral health.

Enquiries:

Financial Dynamics         Tel: +44 20 7831 3113
Ben Atwell/John Gilbert
Sinclair Pharma plc        Tel: +44 1483 410 600
Zoe McDougall              Tel: +44 7973 792 520
John Barrington-Carver     Tel: +44 7831 655 630
Sinclair US
Mike Killeen               Tel: +1 972 478 4380

Copyright © Hugin ASA 2006. All rights reserved.

Contact Information